A carregar...
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
AIMS : Clopidogrel is prescribed for the prevention of atherothrombotic events. While investigations have identified genetic determinants of inter-individual variability in on-treatment platelet inhibition (e.g. CYP2C19*2), evidence that these variants have clinical utility to predict major adverse...
Na minha lista:
| Publicado no: | Eur Heart J Cardiovasc Pharmacother |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363022/ https://ncbi.nlm.nih.gov/pubmed/31504375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcvp/pvz045 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|